Across TCGA pan-cancer cohorts, OOSP1P2 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of OOSP1P2’s most consistent transcriptional readouts.
The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where OOSP1P2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types OOSP1P2 is over-expressed in tumor.
KIRP are the cancer types where OOSP1P2 tumor–normal differential expression is most reproducible.